Brand Refactoring revealed that it discovered evidence suggesting that the current management, including CEO Na Won-gyeon of Dong Sung Bio Pharm, Executive Director Won Yong-min, and Director Namgung ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback